These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31860167)

  • 1. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Meza RI; Sierra T; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Paredes M; Rodríguez A; Juárez SI; Farach N; Videa G; Lara B; Rodríguez E; Ardón E; Sajquim E; Lorenzana R; Ravasi G; Northbrook S; Reyes-Terán G; Ávila-Ríos S
    J Antimicrob Chemother; 2020 Jul; 75(7):1932-1942. PubMed ID: 32303063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.
    Ismael N; Gemusse H; Mahumane I; Laurindo O; Magul C; Baxter C; Wilkinson E; Hofstra LM; Wagar N; Bila D; Mabunda N; da Silva J; Oliveira T; Raizes E; Preiser W; Manuel P; Ramos A; Vúbil A
    BMC Infect Dis; 2024 Jul; 24(1):748. PubMed ID: 39075381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Quezada A; Ruiz L; Arguera N; Sorto S; Nieto AI; Tapia-Trejo D; López-Sánchez DM; Pérez-García M; Cruz L; Andino R; Sajquim E; Juárez SI; Farach N; Ravasi G; Northbrook S; Reyes-Terán G; Ávila-Ríos S
    Open Forum Infect Dis; 2022 Nov; 9(11):ofac580. PubMed ID: 36438615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
    Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
    Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015.
    Avila-Ríos S; García-Morales C; Matías-Florentino M; Tapia-Trejo D; Hernández-Álvarez BF; Moreira-López SE; Quant-Durán CJ; Porras-Cortés G; Reyes-Terán G
    PLoS One; 2016; 11(10):e0164156. PubMed ID: 27736898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment HIV drug resistance among adults initiating ART in Namibia.
    Taffa N; Roscoe C; Sawadogo S; De Klerk M; Baughman AL; Wolkon A; Mutenda N; DeVos J; Zheng DP; Wagar N; Prybylski D; Yang C; Hamunime N; Agolory S; Raizes E
    J Antimicrob Chemother; 2018 Nov; 73(11):3137-3142. PubMed ID: 30137412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.
    Dat VQ; Anh NTL; Van Nghia K; Linh NT; Thu HHK; Tam TTM; Ton T; Anh LQ; Phuc ND; Huong PTT; Nhan DT; Hai NH; Bertagnolio S; Crisp AM; Inzaule S; Dean NE; Jordan MR; Nguyen VTT
    J Int AIDS Soc; 2022 Feb; 25(2):e25857. PubMed ID: 35194954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
    Ávila-Ríos S; García-Morales C; Matías-Florentino M; Romero-Mora KA; Tapia-Trejo D; Quiroz-Morales VS; Reyes-Gopar H; Ji H; Sandstrom P; Casillas-Rodríguez J; Sierra-Madero J; León-Juárez EA; Valenzuela-Lara M; Magis-Rodríguez C; Uribe-Zuñiga P; Reyes-Terán G;
    Lancet HIV; 2016 Dec; 3(12):e579-e591. PubMed ID: 27658867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
    Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: a sub-nationally representative survey.
    Ávila-Ríos S; García-Morales C; Valenzuela-Lara M; Chaillon A; Tapia-Trejo D; Pérez-García M; López-Sánchez DM; Maza-Sánchez L; Del Arenal-Sánchez SJ; Paz-Juárez HE; Quiroz-Morales VS; Mehta SR; Smith DM; León-Juárez EA; Magis-Rodríguez C; Reyes-Terán G;
    J Antimicrob Chemother; 2019 Apr; 74(4):1044-1055. PubMed ID: 30597094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.
    Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA
    J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV drug resistance in persons initiating or reinitiating first-line antiretroviral therapy in Paraguay: Results of a National Patient Survey.
    Aguilar G; Truong HM; Ovelar P; Samudio T; Lopez G; García-Morales C; Tapia-Trejo D; López-Sánchez DM; Ávila-Ríos S; Giron A; De Arias AR; Rios-Gonzalez C; McFarland W
    J Med Virol; 2022 Oct; 94(10):5061-5065. PubMed ID: 35701340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
    Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
    Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.
    Neuhann F; de Forest A; Heger E; Nhlema A; Scheller C; Kaiser R; Steffen HM; Tweya H; Fätkenheuer G; Phiri S
    AIDS Res Ther; 2020 May; 17(1):22. PubMed ID: 32434561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.
    Mirzaei H; Eybpoosh S; Mehrabi F; Shojaei MR; Mirzazadeh A; Khezri M; Nasiri N; Sharifi H
    BMC Infect Dis; 2024 Jan; 24(1):29. PubMed ID: 38166733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
    Moyo S; Hunt G; Zuma K; Zungu M; Marinda E; Mabaso M; Kana V; Kalimashe M; Ledwaba J; Naidoo I; Takatshana S; Matjokotja T; Dietrich C; Raizes E; Diallo K; Kindra G; Mugore L; Rehle T
    PLoS One; 2020; 15(11):e0241071. PubMed ID: 33147285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
    Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS;
    Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
    Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
    Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.